Alto Neuroscience Inc.

NYSE: ANRO · Real-Time Price · USD
3.15
0.03 (0.96%)
At close: Aug 15, 2025, 3:59 PM
3.14
-0.32%
After-hours: Aug 15, 2025, 05:05 PM EDT

Alto Neuroscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
168.23M 82.55M 48.34M 25.7M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
500K n/a n/a n/a
Other Long-Term Assets
4K 131K 55K 50K
Receivables
n/a 8K 546K 1.74M
Inventory
n/a n/a n/a n/a
Other Current Assets
30K 2.31M n/a n/a
Total Current Assets
169.34M 85.39M 49.22M 27.68M
Property-Plant & Equipment
7.7M 1.11M 1.58M 1.06M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
8.21M 1.24M 1.63M 1.11M
Total Assets
177.54M 86.63M 50.85M 28.79M
Account Payables
1.58M 1.07M 1.61M 600K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
870K 125K 283K n/a
Other Current Liabilities
-870K 791K 3.26M 1.19M
Total Current Liabilities
10.01M 5.61M 5.56M 1.81M
Long-Term Debt
11.56M 9.86M 81.7M 38.16M
Other Long-Term Liabilities
4.52M 142.83M 1.88M 1.3M
Total Long-Term Liabilities
16.07M 152.69M 83.7M 39.46M
Total Liabilities
26.08M 158.3M 89.26M 41.27M
Total Debt
16.94M 9.99M 82.11M 38.16M
Common Stock
3K n/a 1K 1K
Retained Earnings
-138.4M -76.97M -40.66M -12.95M
Comprehensive Income
-101K -79K -46K -22K
Shareholders Equity
151.46M -71.67M -38.41M -12.48M
Total Investments
500K n/a n/a n/a